NCT04241328 (SYMBIOSIS) is a clinical trial in Cardiovascular Diseases, sponsored by Medtronic Cardiac Surgery.

Who is sponsoring NCT04241328?

NCT04241328 is sponsored by Medtronic Cardiac Surgery.

What condition does NCT04241328 study?

NCT04241328 studies Cardiovascular Diseases.

Is NCT04241328 still recruiting?

NCT04241328 is currently recruiting now. Last updated 13 April 2026.

Last reviewed 2026-04-13 · How we verify

NCT04241328: SYMBIOSIS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Medtronic SYMBIOSIS Post-Market Registry for Patients Undergoing Cardiac Surgery

Recruiting now Last updated 13 April 2026

What this trial tests

trial in Cardiovascular Diseases in 5,000 participants. Currently enrolling.

Timeline

9 January 2020

Primary endpoint
31 December 2026

31 December 2026

Quick facts

Lead sponsor	Medtronic Cardiac Surgery
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	5,000
Start date	9 January 2020
Primary completion	31 December 2026
Estimated completion	31 December 2026
Sites	14 locations across France, Netherlands, Greece, Belgium, Austria, Germany, Norway, Spain

Conditions studied

Cardiovascular Diseases — all drugs for Cardiovascular Diseases →

Sponsor

Medtronic Cardiac Surgery — full company profile →

Who can join

Eligibility, any sex, with Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this observational, multi-center prospective, post-market registry is to confirm real-world device safety and performance, to ensure the continued acceptability of identified risks, and detect emerging risks.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cardiovascular Diseases

Currently open trials in the same condition.

NCT07442578 — Impact of Exercise Intensity on Cardiac Health in Young Adult Survivors of Childhood Cancer: The PULSE Trial · NA · active not recruiting
NCT07426263 — Effectiveness of a Therapeutic Education Program on Female Sexuality in Women Attending Cardiac Rehabilitation. · NA · active not recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07324278 — Hybrid Stroke Rehab With Mirror Priming · NA · recruiting
NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting

Other Medtronic Cardiac Surgery trials

Trials by the same sponsor.

NCT04073420 — Medtronic Cardiac Surgery PMCF Registry · recruiting
NCT03139721 — Medtronic HAMMOCK Post Approval Study · completed
NCT03283722 — PRESERVE-MITRAL Post-Market Registry · completed
NCT02088554 — PERIGON Pivotal Trial · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04241328 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medtronic Cardiac Surgery
Last refreshed: 13 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04241328.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing